BIIB Competitors
Biogen Inc.
$232.65
-$2.70(-1.15%)
72
Overall
80
Value
91
Tech
47
Quality
Market Cap
$34.37B
Volume
1.46M
52W Range
$138.00 - $240.99
Target Price
$239.19
BIIB competitors: AMGN, GILD, ABBV, PFE, JNJ. Biogen Inc. is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
BIIB Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| AMGN Amgen Inc. | $432.49 | $233.82B | $22.94 | 2.30% | 74 |
| GILD Gilead Sciences, Inc. | $156.19 | $193.67B | $-0.47 | 2.08% | 76 |
| ABBV AbbVie Inc. | $285.42 | $504.37B | $13.94 | 2.39% | 67 |
| PFE Pfizer Inc. | $29.58 | $168.60B | $2.96 | 5.81% | 76 |
| JNJ Johnson & Johnson | $255.56 | $615.87B | $11.10 | 2.07% | 56 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BIIB | $232.65 | -1.1% | 1.46M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |